If you liked this article you might like

Cerner Could Be a Prized Asset for IBM

Cerner Could Be a Prized Asset for IBM

Abbott's Alere Deal Continues To Face Uncertainty

Abbott's Alere Deal Continues To Face Uncertainty

Monsanto Rebuffs Bayer Again

Monsanto Rebuffs Bayer Again

Analyst: Merck's Fundamentals Don't Warrant Current Valuation

Analyst: Merck's Fundamentals Don't Warrant Current Valuation